|
Big Pharma: Share All Trial Results, End Ghostwriting to Boost Credibility
Eight major pharmaceutical companies are calling on drugmakers to publicize all clinical trial results — including unfavorable results — to address a “credibility gap” for industry-sponsored research.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives